Andrea Block1, Sabine Schipf2, Sandra Van der Auwera1, Anke Hannemann3, Matthias Nauck3, Ulrich John4, Henry Völzke2, Harald Jürgen Freyberger1,5, Marcus Dörr6,7, Stephan Felix6,7, Marek Zygmunt8, Henri Wallaschofski3, Hans Jörgen Grabe1,5. 1. a Department of Psychiatry and Psychotherapy , University Medicine Greifswald , Germany ; 2. b Institute for Community Medicine , University Medicine Greifswald , Germany ; 3. c Institute of Clinical Chemistry and Laboratory Medicine , University Medicine Greifswald , Germany ; 4. d Institute of Epidemiology and Social Medicine , University Medicine Greifswald , Germany ; 5. e Department of Psychiatry and Psychotherapy , Helios Hospital Stralsund , Germany ; 6. f Department for Internal Medicine B , University Medicine Greifswald , Germany ; 7. g DZHK (German Center for Cardiovascular Research), Partner Site Greifswald , Greifswald , Germany ; 8. h Department of Obstetrics and Gynaecology , University Medicine Greifswald , Germany.
Abstract
BACKGROUND AND AIMS: Major depressive disorder (MDD) has been associated with the Metabolic Syndrome (MetS). As previous data strongly suggested sex and age effects on this association, this study aimed to analyse the association between MDD and MetS in two general population samples under explicit consideration of sex and age. METHODS: This study analysed cross-sectional data based on two independent general population samples: SHIP-0 (n = 4083; 20-81 years; 49.4% male) and SHIP-TREND-0 (n = 3957; 20-83 years; 49.0% male) that were part of the Study of Health in Pomerania. MDD (SHIP-0: 12.6%; SHIP-TREND-0: 27.2%) was assessed using the Composite International Diagnostic-Screener (CID-S) in both samples. Interview assessment of MDD diagnosis according to Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria was performed in SHIP-TREND-0 (18.1% MDD). MetS was defined by abdominal obesity, elevated blood pressure, elevated glucose, elevated triglycerides and reduced high-density lipoprotein cholesterol according to established criteria. Data analysis was performed sex- and age-stratified. RESULTS: Prevalence of MetS was high in both samples: 19.4% of females and 30.2% of males in SHIP-0 and 22.1% and 33.2% in SHIP-TREND-0, respectively. Effect modifications were observed by sex and age on the association between MDD and MetS. Particularly, younger females (20-49 years) with MDD were more often affected by MetS than younger females without MDD: OR = 2.21 (95% CI = 1.39-3.50). This association vanished in elderly participants (50-82 years). CONCLUSION: The data suggest that especially younger (presumably pre-menopausal) females with MDD are more likely to have MetS than those without major depressive disorders, and that age extenuates this association.
BACKGROUND AND AIMS: Major depressive disorder (MDD) has been associated with the Metabolic Syndrome (MetS). As previous data strongly suggested sex and age effects on this association, this study aimed to analyse the association between MDD and MetS in two general population samples under explicit consideration of sex and age. METHODS: This study analysed cross-sectional data based on two independent general population samples: SHIP-0 (n = 4083; 20-81 years; 49.4% male) and SHIP-TREND-0 (n = 3957; 20-83 years; 49.0% male) that were part of the Study of Health in Pomerania. MDD (SHIP-0: 12.6%; SHIP-TREND-0: 27.2%) was assessed using the Composite International Diagnostic-Screener (CID-S) in both samples. Interview assessment of MDD diagnosis according to Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria was performed in SHIP-TREND-0 (18.1% MDD). MetS was defined by abdominal obesity, elevated blood pressure, elevated glucose, elevated triglycerides and reduced high-density lipoprotein cholesterol according to established criteria. Data analysis was performed sex- and age-stratified. RESULTS: Prevalence of MetS was high in both samples: 19.4% of females and 30.2% of males in SHIP-0 and 22.1% and 33.2% in SHIP-TREND-0, respectively. Effect modifications were observed by sex and age on the association between MDD and MetS. Particularly, younger females (20-49 years) with MDD were more often affected by MetS than younger females without MDD: OR = 2.21 (95% CI = 1.39-3.50). This association vanished in elderly participants (50-82 years). CONCLUSION: The data suggest that especially younger (presumably pre-menopausal) females with MDD are more likely to have MetS than those without major depressive disorders, and that age extenuates this association.
Entities:
Keywords:
Age effects; depression; major depressive disorder; metabolic syndrome; population-based studies; sex effects
Authors: Nawar M Shara; Alexander Zeymo; Zeid Abudiab; Jason G Umans; Soleman Abu-Bader; Asqual Getaneh; Barbara V Howard Journal: J Immigr Minor Health Date: 2018-08
Authors: Laura M Holsen; Grace Huang; Sara Cherkerzian; Sarah Aroner; Eric B Loucks; Steve Buka; Robert J Handa; Jill M Goldstein Journal: J Womens Health (Larchmt) Date: 2021-02-02 Impact factor: 3.017
Authors: Marieke J van Leijden; Brenda W J H Penninx; Charles Agyemang; Miranda Olff; Marcel C Adriaanse; Marieke B Snijder Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-05-23 Impact factor: 4.328
Authors: Leonid N Maslov; Natalia V Naryzhnaya; Alla A Boshchenko; Sergey V Popov; Vladimir V Ivanov; Peter R Oeltgen Journal: J Clin Transl Endocrinol Date: 2018-11-09
Authors: Sarah Kittel-Schneider; Daniel Bury; Karolina Leopold; Sara Haack; Michael Bauer; Steffi Pfeiffer; Cathrin Sauer; Andrea Pfennig; Henry Völzke; Hans-Jörgen Grabe; Andreas Reif Journal: Front Psychiatry Date: 2020-04-22 Impact factor: 4.157